title: [Effects and HPA Axis Related Mechanism of Kaixin-San and Danggui-Shaoyao-San on Glucose and Lipid Metabolism in Chronic Stress Rats with High-fat Diet].
abstract: OBJECTIVE
  To study the effects and potential mechanism of Kaixin-San and Danggui-Shaoyao-San on glucose and lipid metabolism in chronic stress rats fed with high-fat diet.
  
  
  METHODS
  50 male Wistar rats were randomly divided into normal control group (distilled water), high-fat diet with chronic stress group (distilled water), melatonin group(20 mg/kg), Kaixin-San group (445 mg/kg) and Danggui-Shaoyao-San group (3360 mg/kg). All drugs were orally administered. In addition to the normal control group, each group of rats were fed with high-fat, diet. Simultaneously, stress were carried out after drugs administration 1 h daily. The duration was lasted for six weeks. The rat body weight daily was recorded, and the 24 h period urine was collected to detect the level of urine corticosterone (CORT) after three weeks. The level of plasma intraperitoneal glucose tolerance (IVGTT) was detected after six weeks. Finally, rats were executed, and serum fasting blood glucose (FBG), triglyceride (TG), total cholesterol (TC), low-density lipoprotein cholesterol (LDL-C), high density lipoprotein cholesterol (HDL-C), insulin (INS), adrenocorticotropic hormone releasing hormone (CRH), adrenocorticotropic hormone (ACTH), CORT and melatonin ( MLT) were determined. The weight of adrenal gland, liver glycogen and muscle glycogen levels were detected. The adrenal gland index, Homeostasis Model Assessment of Insulin Resistance (HOMA-IR) and insulin sensitivity index( ISI) were calculated.
  
  
  RESULTS
  Compared with normal group, model rats body weight, IVGTT (120 min), plasm CORT were decreased significantly. Serum TG, TC, LDL-C and urine CORT after three weeks were increased significantly. Kaixin-San and Danggui- Shaoyao-San could regulate the above indexes.
  
  
  CONCLUSIONS
  Kaixin-San and Danggui-Shaoyao-San may regulate the activity of HPA axis, and improve glucose and lipid metabolism disorder in model rats by increasing melatonin secretion.
authors.forename: Deng
authors.initials: D
authors.lastname: Wang
authors.forename: Jun
authors.initials: J
authors.lastname: Zhou
authors.forename: Jin
authors.initials: J
authors.lastname: Zhang
authors.forename: Mao-xing
authors.initials: MX
authors.lastname: Li
authors.forename: Jian-guo
authors.initials: JG
authors.lastname: Qiu
authors.forename: Zheng-ping
authors.initials: ZP
authors.lastname: Jia
authors.forename: Ru-xue
authors.initials: RX
authors.lastname: Zhang
mesh_terms: D000818:Animals; D059305:Diet, High-Fat; D004365:Drugs, Chinese Herbal / Q000494:pharmacology*; D005947:Glucose / Q000378:metabolism*; D007030:Hypothalamo-Hypophyseal System; D050356:Lipid Metabolism; D008297:Male; D008550:Melatonin / Q000378:metabolism; D010913:Pituitary-Adrenal System; D051381:Rats; D017208:Rats, Wistar; D013312:Stress, Physiological
chemical_list: D004365:Drugs, Chinese Herbal; C531150:danggui-shaoyao-san; D005947:Glucose; D008550:Melatonin